Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2025 Mar 27:12:1589992.
doi: 10.3389/fmed.2025.1589992. eCollection 2025.

Editorial: Reviews in: pulmonary medicine 2023

Roberto G Carbone  1 , Francesco Puppo  1
Affiliations
Editorial

Editorial: Reviews in: pulmonary medicine 2023

Roberto G Carbone et al. Front Med (Lausanne). .
No abstract available

Keywords: chronic obstructive pulmonary disease; idiopathic pulmonary fibrosis; interstitial lung disease; lung cancer; pulmonary disease; pulmonary hypertension.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.

Comment on

  • Editorial on the Research Topic Reviews in: pulmonary medicine 2023

References

    1. Lin L, Lin Y, Han Z, Wang K, Zhou S, Wang Z, et al. . Understanding the molecular regulatory mechanisms of autophagy in lung disease pathogenesis. Front Immunol. (2024) 15:1460023. 10.3389/fimmu.2024.1460023 - DOI - PMC - PubMed
    1. Rhaman KMT, Islam T, Islam F, Carbone RG, Butzin NC, Ali K. Targeting epigenetics in pulmonaryarterial hypertension. In: Gupta G, Oliver BG, Dua K, Ali K, Dave P, editors. Targeting Epigenetics in Infiammatory Lung Diseases. Singapore: Springer Nature; (2023).
    1. Humbert M, Kovacs G, Hoeper MM, Badagliacca R, Berger RMF, Brida M, et al. . 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. G Ital Cardiol. (2023) 24:e1–e116. - PubMed
    1. Nathan SD, Deng C, King CS, DuBrock HM, Elwing J, Rajagopal S, et al. . Inhaled treprostinil dosage in pulmonary hypertension associated with interstitial lung disease and its effects on clinical outcomes. Chest. (2023) 163:398–406. 10.1016/j.chest.2022.09.007 - DOI - PMC - PubMed
    1. Carbone RG, Monselise A, Puppo F. Treprostinil and clinical outcome in pulmonary hypertension and interstitial lung disease: is all clear? Chest. (2023) 164:e21. 10.1016/j.chest.2023.04.015 - DOI - PubMed

Publication types

LinkOut - more resources